2752-4191

European Heart Journal Open

Oxford University Press

View prefix report (10.1093)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 126 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact126 DOIs
2

Attach ORCID iDs across 33 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact33 DOIs
3

Deposit reference lists for 27 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact27 DOIs

DOIs for this ISSN

Showing the top 5 of 664 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Blood pressure, heart rate, or the Rate Pressure Product: wh… (10.1093/ehjopen/oeac063)
Abstract ORCID
52.07 10
2 An enhanced ceramide-based approach for primary prevention o… (10.1093/ehjopen/oeab016)
Abstract ORCID
50.00 9
3 ChatGPT: the next frontier in academic writing for cardiolog… (10.1093/ehjopen/oead007)
Abstract
49.33 93
4 Evaluation of the cardiac amyloidosis clinical pathway imple… (10.1093/ehjopen/oeac011)
ORCID
36.56 28
5 Targeting cytokine storm in COVID-19: what have we learned? (10.1093/ehjopen/oeab005)
Abstract ORCID
34.95 4
6 The role of inflammation and the possibilities of inflammati… (10.1093/ehjopen/oeac039)
ORCID
34.95 24
7 Adherence to statin therapy: it seems we know everything, ye… (10.1093/ehjopen/oeac071)
Abstract
31.38 17
8 Impact of smoking initiation age on nicotine dependency and… (10.1093/ehjopen/oead135)
References
31.38 17
9 Myeloid cell-derived interleukin-6 induces vascular dysfunct… (10.1093/ehjopen/oeae046)
References
31.38 17
10 Tirzepatide compared with semaglutide and 10-year cardiovasc… (10.1093/ehjopen/oeaf117)
ORCID
31.38 17
11 Aerobic high-intensity interval exercise training in patient… (10.1093/ehjopen/oead030)
ORCID
28.65 13
12 Revisiting secondary mitral regurgitation threshold severity… (10.1093/ehjopen/oeae084)
ORCID
26.03 10
13 Lipoprotein(a): the enemy that we still don’t know how to de… (10.1093/ehjopen/oead080)
Abstract
25.00 9
14 Dyssynchrony and resynchronization in heart failure - Effect… (10.1093/ehjopen/oead058)
Abstract References
23.86 2
15 Incident atrial fibrillation and adverse clinical outcomes d… (10.1093/ehjopen/oead047)
References
22.58 7
16 Prognostic implication of liver fibrosis scores in patients… (10.1093/ehjopen/oead082)
ORCID
22.58 7
17 Balancing bleeding and valve thrombosis risk after transcath… (10.1093/ehjopen/oeae022)
Abstract
22.58 7
18 New data allow to better understand the secrets of lipoprote… (10.1093/ehjopen/oeae066)
Abstract
22.58 7
19 Human immunodeficiency virus infection and risks of morbidit… (10.1093/ehjopen/oeab040)
ORCID
21.13 6
20 Sotatercept for the treatment of pulmonary arterial hyperten… (10.1093/ehjopen/oead086)
Abstract
21.13 6
21 Is non-cardiac death increased with an initial invasive reva… (10.1093/ehjopen/oeac012)
Abstract
19.45 5
22 Environmental pollution’s toll on the heart: rethinking card… (10.1093/ehjopen/oeae017)
Abstract
19.45 5
23 Antibodies against angiotensin II type 1 and endothelin-1 ty… (10.1093/ehjopen/oeae099)
Abstract
19.45 5
24 Feasibility and safety of cangrelor in patients with subopti… (10.1093/ehjopen/oeab028)
Abstract
17.47 4
25 Screening for atrial fibrillation: less is more? (10.1093/ehjopen/oeab038)
Abstract
17.47 4
26 Serial changes of layer-specific myocardial function accordi… (10.1093/ehjopen/oeac008)
ORCID
17.47 4
27 Exploring the link between Gilbert’s syndrome and atheroscle… (10.1093/ehjopen/oead059)
Abstract
17.47 4
28 One-year follow-up of patients treated with single antiplate… (10.1093/ehjopen/oead075)
Abstract
17.47 4
29 Utility of electrocardiographic findings in acute pulmonary… (10.1093/ehjopen/oead121)
Abstract
17.47 4
30 Remnant cholesterol concentrations best explain the cardiova… (10.1093/ehjopen/oeaf018)
References
17.47 4
31 Efficacy and safety of renal denervation therapy in hyperten… (10.1093/ehjopen/oeaf026)
Abstract
17.47 4
32 Prediction of major bleeding events for patients with dual a… (10.1093/ehjopen/oeaf137)
Abstract
17.47 4
33 Cardiotoxicity assessment in breast cancer patients: is it s… (10.1093/ehjopen/oeac020)
Abstract ORCID
15.05 1
34 ‘Remote dielectric sensing to detect acute heart failure in… (10.1093/ehjopen/oead006)
Abstract References
15.05 1
35 Dietary salt intake and atherosclerosis: an area not fully e… (10.1093/ehjopen/oead025)
Abstract
15.05 3
36 Cardio-ankle vascular index predicts postoperative atrial fi… (10.1093/ehjopen/oead042)
Abstract
15.05 3
37 Increased cardiovascular mortality during the COVID-19 pande… (10.1093/ehjopen/oead119)
Abstract
15.05 3
38 Causes of long-term mortality in patients with ST-segment el… (10.1093/ehjopen/oeaf002)
Abstract
15.05 3
39 Comparative efficacy and procedural outcomes of pulsed field… (10.1093/ehjopen/oeaf092)
Abstract
15.05 3
40 Early Aortic Valve Intervention in Asymptomatic Severe Aorti… (10.1093/ehjopen/oeaf114)
References
15.05 3
41 Unmasking flawed exposure attribution in nicotine and cardio… (10.1093/ehjopen/oeag059)
Abstract ORCID
15.05 1
42 Troponin measurement in routine clinical practice: the reali… (10.1093/ehjopen/oeac049)
Abstract
11.93 2
43 A new score to stratify the risk in tricuspid regurgitation:… (10.1093/ehjopen/oeac068)
Abstract
11.93 2
44 Metabolic syndrome cardiovascular risk prevention by omega-3… (10.1093/ehjopen/oead115)
Abstract
11.93 2
45 Women in Cardiology (10.1093/ehjopen/oead122)
Abstract
11.93 2
46 Impact of hypoxic hepatitis in cardiogenic shock: a substudy… (10.1093/ehjopen/oeae024)
Abstract
11.93 2
47 Myeloid-specific interleukin-6 response: from vascular effec… (10.1093/ehjopen/oeae047)
Abstract
11.93 2
48 Colchicine improves clinical outcomes in patients with coron… (10.1093/ehjopen/oeae063)
Abstract
11.93 2
49 Percutaneous thrombectomy with the FlowTriever for pulmonary… (10.1093/ehjopen/oeae092)
Abstract
11.93 2
50 Rationale and design of the ADA-HF (Acetazolamide as a chlor… (10.1093/ehjopen/oeaf019)
References
11.93 2